UCL Translational Research Office
@ucltro.bsky.social
We drive the translation of UCL's science into healthcare innovations and foster industry-academia partnerships. Contact us for:
Translational strategy | Project management | Funding applications | Business partnerships | Industry-sponsored research
Translational strategy | Project management | Funding applications | Business partnerships | Industry-sponsored research
@uclenterprise.bsky.social @uclb.bsky.social @uclbrainscience.bsky.social @uclqsion.bsky.social @bia-uk.bsky.social
November 6, 2025 at 12:30 PM
Reposted by UCL Translational Research Office
UCL’s Translational Research Office (TRO) worked closely with Professor Giunti and the industry partner to advance the research and help deliver innovative therapies through strategic collaboration.
Find out more: bit.ly/3FPYMW7
#KEF5
@ucl.ac.uk @ucltro.bsky.social @uclnews.bsky.social
Find out more: bit.ly/3FPYMW7
#KEF5
@ucl.ac.uk @ucltro.bsky.social @uclnews.bsky.social
First treatment for rare disease approved by UK medicines regulator
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCL and UCLH led the UK trial – has been approved for use in the UK by the medicines’ regulator.
bit.ly
September 24, 2025 at 8:14 AM
UCL’s Translational Research Office (TRO) worked closely with Professor Giunti and the industry partner to advance the research and help deliver innovative therapies through strategic collaboration.
Find out more: bit.ly/3FPYMW7
#KEF5
@ucl.ac.uk @ucltro.bsky.social @uclnews.bsky.social
Find out more: bit.ly/3FPYMW7
#KEF5
@ucl.ac.uk @ucltro.bsky.social @uclnews.bsky.social